Bio-Techne (TECH) Non-Current Deferred Tax Liability (2011 - 2026)

Bio-Techne's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 55.49% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (down 55.49% YoY), while the FY2025 annual figure was $6.2 million, down 88.96% from the prior year.
• Non-Current Deferred Tax Liability was $14.2 million for Q1 2026 at Bio-Techne, up from $11.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $112.9 million in Q3 2022 to a low of $4.1 million in Q3 2023.
• Historically, Non-Current Deferred Tax Liability has averaged $56.7 million across 5 years, with a median of $55.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability plunged 96.37% in 2023, then surged 1119.93% in 2024.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $111.4 million in 2022, then plunged by 35.74% to $71.6 million in 2023, then slumped by 47.3% to $37.7 million in 2024, then slumped by 70.78% to $11.0 million in 2025, then rose by 28.94% to $14.2 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $14.2 million (Q1 2026), $11.0 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.